Stockscreener 앱 받기
9.08
1.94%
-0.18
시간 외 거래:
9.08
전일 마감가:
$9.26
열려 있는:
$9.24
하루 거래량:
342.56K
Relative Volume:
0.78
시가총액:
$1.30B
수익:
$6.32B
순이익/손실:
$230.14M
주가수익비율:
9.4603
EPS:
0.9598
순현금흐름:
$256.03M
1주 성능:
-2.58%
1개월 성능:
-10.10%
6개월 성능:
+1.57%
1년 성능:
-28.56%
1일 변동 폭
$9.05
$9.66
1주일 범위
$9.05
$9.775
52주 변동 폭
$7.71
$15.48
Ardent Health Inc Stock (ARDT) Company Profile
명칭
Ardent Health Inc
전화
(615) 296-3000
주소
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, DVA, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARDT
Ardent Health Inc
|
9.08 | 1.36B | 6.32B | 230.14M | 256.03M | 0.9598 |
HCA
Hca Healthcare Inc
|
388.16 | 86.51B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
178.50 | 15.43B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
210.58 | 13.46B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.57 | 12.60B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
97.89 | 9.86B | 6.07B | 793.80M | 464.40M | 5.9914 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-17 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-14 | 개시 | Goldman | Neutral |
| 2025-09-10 | 개시 | UBS | Buy |
| 2025-07-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-11-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-12 | 개시 | BofA Securities | Buy |
| 2024-08-12 | 개시 | Citigroup | Buy |
| 2024-08-12 | 개시 | JP Morgan | Neutral |
| 2024-08-12 | 개시 | Leerink Partners | Outperform |
| 2024-08-12 | 개시 | Loop Capital | Buy |
| 2024-08-12 | 개시 | Mizuho | Outperform |
| 2024-08-12 | 개시 | Morgan Stanley | Overweight |
| 2024-08-12 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-12 | 개시 | Stephens | Overweight |
| 2024-08-12 | 개시 | Truist | Buy |
모두보기
Ardent Health Inc 주식(ARDT)의 최신 뉴스
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-06-14 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Ardent Health (ARDT) Slips 3% as Stock Tests Support Levels Amid Sector WeaknessKey Reversal Day - newsline.com
Layoffs, closures tracker: Layoffs at two Ardent Health systems - Modern Healthcare
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $12 to $13.5 - Moomoo
Ardent Health (ARDT) Slips 3.31% as Resistance Holds, Support Near $8.88 in FocusPullback Trade - newsline.com
Ardent Health (ARDT) Slips 3.31% as Stock Tests Key Support LevelsHedge Fund Exposure - newsline.com
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares? - Yahoo Finance
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares? - The Motley Fool
Ardent Health Q1 2026 Earnings: EPS Beat of 48.62% Overshadowed by Stock DeclinePretax Income Report - newsline.com
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Chutes & Ladders—AMA elects its next president; Ardent Health appoints new CEO - Fierce Healthcare
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Ardent Health Q1 2026 Earnings: Strong EPS Beat Drives Positive Stock ReactionEarnings Miss Alert - newsline.com
symbol__ Stock Quote Price and Forecast - CNN
Insider Buying: Alfred Lumsdaine Acquires Shares of Ardent Healt - GuruFocus
Ardent health director Robert DeMichiei buys $98,299 in stock By Investing.com - Investing.com South Africa
Ardent health CFO Alfred Lumsdaine buys $88,100 in company stock By Investing.com - Investing.com South Africa
Ardent health director Robert DeMichiei buys $98,299 in stock - Investing.com India
Ardent health CFO Alfred Lumsdaine buys $88,100 in company stock - Investing.com
Ardent Health (ARDT) director adds 11,260 shares in open-market buy - Stock Titan
Ardent Health (ARDT) CFO boosts stake with 10,000-share purchase - Stock Titan
Ardent Health, Inc. Stock 12‑Month Price Target Cut to $12.41, Implies 43% Upside - TradingView
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will Ardent Health’s (ARDT) New CEO Shift the Focus of Its Post-IPO Efficiency Narrative? - Yahoo Finance
2026-06-07 | Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
A Look At Ardent Health (ARDT) Valuation As New CEO Dave Caspers Takes The Helm - Yahoo Finance
Ardent Health (ARDT) Edges Higher on Modest Volume as Stock Tests Mid-Range LevelsOption Strike Build - newsline.com
BofA raises Ardent Health stock price target on strong Q1 results - Investing.com
Ardent Health Award Spotlights AI Focus As Valuation And Margins Questioned - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - The National Law Review
CEO Bonick Leaves Hospital Operator Ardent - HCI Innovation Group
Ardent Health Names Dave Caspers CEO Amid Transformation - The Globe and Mail
Goldman Sachs health conference to feature Ardent Health webcast on June 10 - Stock Titan
Ardent Health to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
New Ardent Health CEO inherits growth ambitions - Healthcare Dive
Why is Ardent Health Partners stock plunging today? - Investing.com
Why is Ardent Health Partners stock plunging today? By Investing.com - Investing.com Canada
Ardent Health Appoints Dave Caspers as CEO, Reaffirms 2026 EBITDA Guidance and Focuses on Operational Growth 12 - Minichart
Ardent Health Partners stock hits 52-week low at $7.93 - Investing.com
Ardent Health Partners stock hits 52-week low at $7.93 By Investing.com - Investing.com Canada
From Walmart Health to the C-suite: Dave Caspers takes over Ardent Health - Stock Titan
Ardent Health names insider Dave Caspers CEO - MSN
Ardent Health names Dave Caspers CEO as Marty Bonick steps down - Modern Healthcare
Ardent Health Appoints Dave Caspers As CEO - TradingView
Ardent Health names Dave Caspers as new CEO By Investing.com - Investing.com Canada
Ardent Health (NYSE: ARDT) elevates Dave Caspers to CEO and reaffirms 2026 EBITDA outlook - Stock Titan
Ardent Health Announces CEO Changes, Effective June 2, 2026 - marketscreener.com
Ardent Health Inc (ARDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
0.50%
자본화:
|
볼륨(24시간):